Publications

  1. Roden AC, Maleszewski JJ, Yi ES, Jenkins SM, Gandhi MJ, Scott JP, Christine Aubry M. Reproducibility of Complement 4d deposition by immunofluorescence and immunohistochemistry in lung allograft biopsies. J Heart Lung Transplant. 2014 Jun 18. [Epub ahead of print]
    View PubMed
  2. Wylam ME, Kennedy CC, Hernandez NM, Peters SG, Maleszewski JJ, Cassivi SD, Scott JP. Fatal hyperammonaemia caused by Mycoplasma hominis. Lancet. 2013 Dec 7; 382(9908):1956.
    View PubMed
  3. Tomaszek SC, Fibla JJ, Dierkhising RA, Scott JP, Shen KR, Wigle DA, Cassivi SD. Outcome of lung transplantation in elderly recipients. Eur J Cardiothorac Surg. 2011 May; 39(5):726-31. Epub 2010 Nov 16.
    View PubMed
  4. McKellar SH, Durham LA 3rd, Scott JP, Cassivi SD. Successful lung transplant from donor after cardiac death: a potential solution to shortage of thoracic organs. Mayo Clin Proc. 2010 Feb; 85(2):150-2.
    View PubMed
  5. Stewart S, Fishbein MC, Snell GI, Berry GJ, Boehler A, Burke MM, Glanville A, Gould FK, Magro C, Marboe CC, McNeil KD, Reed EF, Reinsmoen NL, Scott JP, Studer SM, Tazelaar HD, Wallwork JL, Westall G, Zamora MR, Zeevi A, Yousem SA. Revision of the 1996 working formulation for the standardization of nomenclature in the diagnosis of lung rejection. J Heart Lung Transplant. 2007 Dec; 26(12):1229-42.
    View PubMed
  6. Snell GI, Boehler A, Glanville AR, McNeil K, Scott JP, Studer SM, Wallwork J, Westall G, Zamora MR, Stewart S. Eleven years on: a clinical update of key areas of the 1996 lung allograft rejection working formulation. J Heart Lung Transplant. 2007 May; 26(5):423-30.
    View PubMed
  7. Schrage WG, Wilkins BW, Dean VL, Scott JP, Henry NK, Wylam ME, Joyner MJ. Exercise hyperemia and vasoconstrictor responses in humans with cystic fibrosis. J Appl Physiol (1985). 2005 Nov; 99(5):1866-71. Epub 2005 Jul 21.
    View PubMed
  8. Peters SG, Afessa B, Decker PA, Schroeder DR, Offord KP, Scott JP. Increased risk associated with pulmonary artery catheterization in the medical intensive care unit. J Crit Care. 2003 Sep; 18(3):166-71.
    View PubMed
  9. Utz JP, Limper AH, Kalra S, Specks U, Scott JP, Vuk-Pavlovic Z, Schroeder DR. Etanercept for the treatment of stage II and III progressive pulmonary sarcoidosis. Chest. 2003 Jul; 124(1):177-85.
    View PubMed
  10. Saydain G, Islam A, Afessa B, Ryu JH, Scott JP, Peters SG. Outcome of patients with idiopathic pulmonary fibrosis admitted to the intensive care unit. Am J Resp Crit Care Med. 2002 Sep 15; 166(6):839-42.
    View PubMed
  11. Wijdicks EF, Scott JP. Stroke in the medical intensive-care unit. Mayo Clin Proc. 1998 Jul; 73(7):642-6.
    View PubMed
  12. Palmas A, Tefferi A, Myers JL, Scott JP, Swensen SJ, Chen MG, Gastineau DA, Gertz MA, Inwards DJ, Lacy MQ, Litzow MR. Late-onset noninfectious pulmonary complications after allogeneic bone marrow transplantation. Br J Haematol. 1998 Mar; 100(4):680-7.
    View PubMed
  13. Scott JP. Boom or bust, the economics of financial reform. J Int Soc Phil Inquiry. 1998; 12:63-4.
  14. Galanis E, Litzow MR, Tefferi A, Scott JP. Spontaneous pneumomediastinum in a patient with bronchiolitis obliterans after bone marrow transplantation. Bone Marrow Transplant. 1997 Oct; 20(8):695-6.
    View PubMed
  15. Wijdicks EF, Scott JP. Pulmonary embolism associated with acute stroke. Mayo Clin Proc. 1997 Apr; 72(4):297-300.
    View PubMed
  16. Wijdicks EF, Scott JP. Causes and outcome of mechanical ventilation in patients with hemispheric ischemic stroke. Mayo Clin Proc. 1997 Mar; 72(3):210-3.
    View PubMed
  17. Scott JP, Peters SG, McDougall JC, Beck KC, Midthun DE. Posttransplantation physiologic features of the lung and obliterative bronchiolitis. Mayo Clin Proc. 1997 Feb; 72(2):170-4.
    View PubMed
  18. Midthun DE, McDougall JC, Peters SG, Scott JP. Medical management and complications in the lung transplant recipient. Mayo Clin Proc. 1997 Feb; 72(2):175-84.
    View PubMed
  19. Peters SG, McDougall JC, Scott JP, Midthun DE, Jowsey SG. Lung transplantation: selection of patients and analysis of outcome. Mayo Clin Proc. 1997 Jan; 72(1):85-8.
    View PubMed
  20. Speziali G, McDougall JC, Midthun DE, Peters SG, Scott JP, Daly RC, McGregor CG. Native lung complications after single lung transplantation for emphysema. Transpl Int. 1997; 10(2):113-5.
    View PubMed
  21. Wijdicks EF, Scott JP. Outcome in patients with acute basilar artery occlusion requiring mechanical ventilation. Stroke. 1996 Aug; 27(8):1301-3.
    View PubMed
  22. Scott JP, Beck KC, Peters SG, Gillespie DJ, McDougall JC, Midthun DE, Daly RC, McGregor CG, Mercill S. Survival in lung transplantation. Transplant Proc. 1996 Feb; 28(1):269.
    View PubMed
  23. Scott JP, Beck KC, Gillespie DJ, Peters SG, Midthun DE, McDougall JC, Daly RC, McGregor CG. Reduced work of breathing following single lung transplantation for emphysema. Transplant Proc. 1995 Feb; 27(1):1293-4.
    View PubMed
  24. Scott JP, Gillespie DJ, Peters SG, Beck KC, Midthun DE, McDougall JC, Daly RC, McGregor CG. Reduced work of breathing after single lung transplantation for emphysema. J Heart Lung Transplant. 1995 Jan-Feb; 14(1 Pt 1):39-43.
    View PubMed
  25. Scott JP. Cystic Fibrosis. Primepractice. 1995; 2:part 3.
  26. Scott JP. Pulmonary Hypertension. Primepractice 2;part 3 1995.
  27. McGregor CG, Daly RC, Peters SG, Midthun DE, Scott JP, Allen MS, Tazelaar HD, Keating MR, Walker RC, McDougall JC. Evolving strategies in lung transplantation for emphysema. Ann Thorac Surg. 1994 Jun; 57(6):1513-20; discussion 1520-1.
    View PubMed
  28. Sharples LD, Scott JP, Dennis C, Higenbottam TW, Stewart S, Wreghitt T, Large SR, Wells FC, Wallwork J. Risk factors for survival following combined heart-lung transplantation. The first 100 patients. Transplantation. 1994 Jan; 57(2):218-23.
    View PubMed
  29. Scott JP, Whitehead B, De Leval M, Helms P, Smyth RL, Higenbottam TW, Wallwork J. Paediatric incidence of acute rejection and obliterative bronchiolitis: a comparison with adults. Transplant Int. 1994; 7 Suppl 1:404-6.
  30. Scott JP, Holt DW, Wallwork J. Neutrophil elastase and Obliterative Bronchiolitis. Transplant Int. 1994; 7 Suppl 1:402-3.
  31. Scott JP. The role of bronchoscopy in the lung transplant patient. J Bronchology 1: 1994; 1994:135-43.
  32. Higenbottam TW, Spiegelhalter D, Scott JP, Fuster V, Dinh-Xuan AT, Caine N, Wallwork J. Prostacyclin (epoprostenol) and heart-lung transplantation as treatments for severe pulmonary hypertension. Br Heart J. 1993 Oct; 70(4):366-70.
    View PubMed
  33. Scott JP, Dennis C, Mullins P. Heart-lung transplantation for end-stage respiratory disease in cystic fibrosis patients. J R Soc Med. 1993; 86 Suppl 20:19-22.
    View PubMed
  34. Sharples LD, Scott JP, Dennis C, Higenbottam TW, Wells FC, Large SR, Wallwork J. Risk factors for early and medium term death following combined heart and lung transplantation. Amer Rev Resp Dis. 1993; 147:A341.
  35. Clelland C, Higenbottam T, Stewart S, Otulana B, Wreghitt T, Gray J, Scott J, Wallwork J. Bronchoalveolar lavage and transbronchial lung biopsy during acute rejection, infection in heart-lung transplant patients. Am Rev Resp Dis. 1993; 147:1386-92.
    View PubMed
  36. Mullins PA, Scott JP, Aravot DJ, Dennis C, Large SR, Wallwork J, Schofield PM. Coronary flow reserve and coronary occlusive disease. Transpl Int. 1992; 5 Suppl 1:S252-4.
  37. Mullins P, Scott J, Aravot D, Dennis C, Large S, Wallwork J, Schofield P. Coronary flow reserve is impaired early after cardiac transplantation. Transpl Int. 1992; 5 Suppl 1:S234-7.
  38. Scott JP, Wallwork J. The use of allopurinol in the inhibition of obliterative bronchiolitis of the transplanted lung. Transpl Int. 1992; 5 Suppl 1:S246-8.
    View PubMed
  39. Morrison JF, Higenbottam TW, Hathaway TJ, Clelland C, Scott JP, Wallwork J. Diurnal variation in FEV1 following heart-lung transplantation. Eur Respir J. 1992 Jul; 5(7):834-40.
  40. Mullins PA, Cary NR, Sharples L, Scott J, Aravot D, Large SR, Wallwork J, Schofield PM. Coronary occlusive disease and late graft failure after cardiac transplantation. Br Heart J. 1992 Sep; 68(3):260-5.
    View PubMed
  41. Scott JP, Wallwork J. Prevention of obliterative bronchiolitis in heart-lung transplant recipients by xanthine oxidase inhibition. Transpl Int. 1992; 5 Suppl 1:S246-8.
  42. Scott JP, Higenbottam TW, Large S, Wallwork J. Cyclosporine in heart transplant recipients: an exercise study of vasopressive effects. Eur Heart J. 1992 Apr; 13(4):531-4.
    View PubMed
  43. Scott JP, Otulana BA, Mullins PA, Aravoj DJ, Higenbottam TW, Wallwork J. Late pulmonary haemodynamic changes in heart-lung transplantation. Eur Heart J. 1992 Apr; 13(4):503-7.
  44. Mullins P, Scott J, Aravot D, Dennis C, Large S, Wallwork J, Schofield P. Coronary flow is impaired early after cardiac transplantation. Transpl Int. 1992; 5 Suppl 1:S234-7.
  45. Mullins P, Schofield P, Dunning J, Scott J, Aravot D, Large S, Cary N, Wallwork J, Stone D. The use of exercise technetium-99m 2-methoxy-isobutyl-isonitrile(99mTc-Sestamibi) perfusion scanning in the detection of acute rejection after cardiac transplantation. J Nucl Biol Med. 1992 Jan-Mar; 36(1):2-6.
    View PubMed
  46. Whitehead B, Scott JP, Helms P, Malone M, Macrae D, Higenbottam TW, Smyth RL, Wallwork J, Elliott M, de Leval M. Technique and use of transbronchial biopsy in children and adolescents. Pediatric Pulmonology. 1992 Apr; 12(4):240-6.
    View PubMed
  47. Mullins PA, Scott JP, Dunning JJ, Aravot DJ, Large SR, Wallwork J, Schofield PM. Cardiac transplant waiting lists, donor shortage and retransplantation and implications for using donor hearts. Am J Cardiol. 1991 Aug 1; 68(4):408-9.
    View PubMed
  48. Mullins P, Scott J, Chauhan A, Graham T, Aravot D, Large S, Schofield P, Wallwork J. Acute heart retransplantation. Lancet. 1991 Jun 22; 337(8756):1552-3.
  49. Smyth RL, Scott JP, Borysiewicz LK, Sharples LD, Stewart S, Wreghitt TG, Gray JJ, Higenbottam TW, Wallwork J. Cytomegalovirus infection in heart-lung transplant recipients: risk factors, clinical associations, and response to treatment. J Infect Disease. 1991 Dec; 164(6):1045-50.
  50. Whitehead B, Helms P, Goodwin M, Martin I, Lask B, Serrano E, Scott JP, Smyth RL, Higenbottam TW, Wallwork J, Elliot M, deLeval M. Heart-lung transplantation for cystic fibrosis 1; Assessment. Arch Dis Child. 1991 Sep; 66(9):1018-21; discussion 1016-7.
  51. Whitehead B, Helms P, Goodwin M, Martin I, Scott JP, Smyth RL, Higenbottam TW, Wallwork J, Elliott M, deLeval M. Heart-lung transplantation for cystic fibrosis 2: Outcome. Arch Dis Child. 1991 sep; 66(9):1022-6; discussion 1016-7.
    View PubMed
  52. Scott JP, Higenbottam TW, Hutter JA, Large S, Wallwork J. Effects of the immunosuppressant cyclosporine on the circulation of heart transplant recipients. Am J Cardiol. 1991 Mar 15; 67(7):628-32.
    View PubMed
  53. Scott JP, Fradet G, Smyth RL, Mullins P, Pratt A, Clelland CA, Higenbottam T, Wallwork J. Prospective study of transbronchial biopsies in the management of heart-lung and single lung transplant patients. J Heart Transplant. 1991 Sep-Oct; 10(5 Pt 1):626-36; discussion 636-7.
  54. Scott JP, Sharples L, Mullins P, Aravot DJ, Stewart S, Otulana BA, Higenbottam TW, Wallwork J. Further studies on the natural history of obliterative bronchiolitis following heart-lung transplantation. Transplant Proc. 1991 Feb; 23(1 Pt 2):1201-2.
    View PubMed
  55. Scott JP, Higenbottam TW, Smyth RL, Wallwork J. An acute pulmonary hypertensive crisis in a patient with primary pulmonary hypertension treated by both epoprostenol(prostacyclin) and nitroprusside. Chest. 1991 May; 99(5):1284-5.
    View PubMed
  56. Smyth RL, Higenbottam T, Scott J, Wallwork J. Cystic Fibrosis. 5. The current status of lung transplantation for cystic fibrosis. Thorax. 1991 Mar; 46(3):213-6.
    View PubMed
  57. Caine N, Sharples LD, Smyth R, Scott J, Hathaway T, Higenbottam TW, Wallwork J. Survival and quality of life of cystic fibrosis patients before and after heart-lung transplantation. Transplant Proc. 1991 Feb; 23(1 Pt 2):1203-4.
    View PubMed
  58. Smyth RL, Sinclair J, Scott JP, Gray JJ, Higenbottam TW, Wreghitt TG, Wallwork J, Borysiewicz L. Infection and reactivation with cytomegalovirus strains in lung transplant recipients. Transplantation. 1991 Sep; 52(3):480-2.
    View PubMed
  59. de Leval MR, Smyth R, Whitehead B, Scott JP, Elliott MJ, Caine N, Helms P, Sharples L, Martin IR, Higenbottam T, Wallwork J. Heart and Lung Transplantation for terminal Cystic Fibrosis. A four and a half year experience. J Thorac Cardiovasc Surg. 1991 Apr; 101(4):633-41; discussion 641-2.
  60. Mullins PA, Shapiro LM, Aravot DA, Scott JP, Large SR, Wallwork J, Schofield PM. Experience of percutaneous transluminal coronary angioplasty in orthotopic cardiac transplant recipients. European Heart J. 1991 Nov; 12(11):1205-7.
    View PubMed
  61. Sharples LD, Caine N, Mullins P, Scott JP, Solis E, English TA, Large SR, Schofield PM, Wallwork J. Risk factors for coronary occlusive disease following heart transplantation - rejection, infection and coronary occlusive disease. Transplantation. 1991 Aug; 52(2):244-52.
    View PubMed
  62. Aravot D, Scott J, Mullins P, Dennis C, Caine N, Large S, Wallwork J. Outcome of organs shared in the "domino" procedure. Transpl Proc. 1991 Oct; 2395):2612-3.
  63. Grace AA, Newell SA, Cary NR, Scott JP, Large SR, Wallwork J, Schofield PM. Diagnosis of early cardiac transplant rejection by fall in evoked T wave amplitude measured using an externalised QT drive rate responsive pacemaker. Pacing Clin Electrophysiol. 1991 Jun; 14(6):1024-31.
    View PubMed
  64. Scott JP, Higenbottam TW, Sharples L, Clelland CA, Smyth RL, Stewart S, Wallwork J. Risk factors for obliterative bronchiolitis in heart-lung transplant recipients. Transplantation. 1991 Apr; 51(4):813-7.
    View PubMed
  65. Scott JP, Higenbottam TW, Clelland CA, Smyth RL, Stewart S, Wallwork J. The natural hisotry of chronic rejection in heart-lung transplant recipients: a clinical, pathological, and physiological review of 29 long-term survivors. Transplant Proc. 1990 Aug;22(4):1474-6.
    View PubMed
  66. Clelland CA, Higenbottam TW, Monk JA, Scott JP, Smyth RL, Wallwork J. Bronchoalveolar lavage lymphocytes in relation to transbronchial lung biopsies in heart-lung transplants. Transplant Proc. 1990 Aug;22(4):1479.
    View PubMed
  67. Scott JP, Higenbottam T, Wallwork J. The acute effect of the synthetic prostacyclin analogue iloprost in primary pulmonary hypertension. Br J Clin Pract. 1990 Jun; 44(6):231-4.
  68. McGoldrick JP, Forty J, Scott JP, Smyth RL, Higenbottam T, Wallwork J. Heart-lung transplantation: graft function postoperatively. Transplant Proc. 1990 oct; 22(5):2132-3.
  69. Scott JP, Higenbottam TW, Smyth RL, Whitehead B, Helms P, Fradet G, De Leval M, Wallwork J. Transbronchial biopsies in children after heart-lung transplantation. Pediatrics. 1990 Nov; 86(5):698-702.
    View PubMed
  70. Scott JP, Fradet G, Smyth RL, Solis E, Higenbottam TW, Wallwork J. Management following heart and lung transplantation: five years experience. Eur J Cardiothorac Surg. 1990; 4(4):197-200; discussion 201.
  71. Scott JP, Higenbottam TW, Clelland CA, Stewart S, Smyth RL, McGoldrick JP, Otulana BA, Wallwork J. Natural history of chronic rejection in heart-lung transplant recipients. J Heart Transplant. 1990 Sep-Oct; 9(5):510-15.
    View PubMed
  72. Scott JP, Higenbottam TW, Hutter JA, Smyth RL, Glandville C, Wallwork J. Cardiovascular effects of cyclosporine in heart transplant recipients. Transplant Proc. 1990 Aug; 2294):1740-41.
    View PubMed
  73. Scott JP, Couetil JP, Serrano-Fiz S, Higenbottam TW, Wallwork J. Combined heart and lung transplantation Pneumologisches Kolloqium. 1990; 5:77-88.
  74. Scott JP, Hay IF, Higenbottam TW, Evans D, Calne RY. Hypertensive exercise responses in ciclosporin-treated normotensive renal transplant recipients. Nephron. 1990; 56(2):143-7.
    View PubMed
  75. Otulana BA, Higenbottam T, Ferrari L, Scott JP, Igboaka G, Wallwork J. The use of home spirometry in detecting acute lung rejection and infection following heart-lung transplantation. Chest. 1990 Feb; 97(2):353-7.
    View PubMed
  76. Fradet G, Smyth RL, Scott JP, Solis E, Sharples L, Higenbottam TW, Wallwork J. Cystic fibrosis: a new challenge for cardiothoracic surgery. Eur J Cardiothorac Surg. 1990; 4(3):136-40; discussion 140-1.
  77. Smyth RL, Higenbottam TW, Scott JP, Wreghitt TG, Stewart S, Clelland CA, McGoldrick JP, Wallwork J. Herpes simplex virus infection in heart-lung transplant recipients. Transplantation. 1990 Apr; 49(4):735-9.
    View PubMed
  78. Clelland CA, Higenbottam TW, Stewart S, Scott JP, Wallwork J. The histological changes in transbronchial biopsy after treatment of acute lung rejection in heart-lung transplants. J Pathol. 1990 Jun; 161(2):105-12.
    View PubMed
  79. Dinh-Xuan AT, Higenbottam TW, Scott JP, Wallwork J. Primary Pulmonary Hypertension: Diagnosis, medical and surgical treatment. Respir Med. 1990 May; 84(3):189-97.
    View PubMed
  80. Otulana BA, Higenbottam TW, Scott JP, Wallwork J. A possible role for mixed venous blood changes in the hyperventilation of exercise in heart-lung transplant recipients. Aspen Lung Conference: Chronic Respiratory Failure. Chest. 1990; 97(3 Suppl):88S-9S.
    View PubMed
  81. Clelland CA, Higenbottam TW, Otulana BA, Stewart S, Scott JP, McGoldrick J, Wallwork J. Histological grading of acute lung rejection on transbronchial biopsy helps predict long-term outcome of heart-lung transplants. Transplant Proc. 1990 Aug; 22(4):1480.
    View PubMed
  82. Clelland C, Higenbottam T, Otulana B, Stewart S, Igboaka G, Scott J, Smyth R, Wallwork J. Histologic prognostic indicators for the lung allografts of heart-lung transplants. J Heart Transplant. 1990 Jun; 9(3 Pt 1):177-85; discussion 185-6.
    View PubMed
  83. Pepke-Zaba J, Higenbottam TW, Dinh Xuan AT, Scott JP, English TA, Wallwork J. Validation of impedance cardiography measurements of cardiac output during limited exercise in heart transplant recipients. Transplant Int. 1990 Jul; 3(2):108-12.
  84. Smyth RL, Scott JP, Whitehead B, Fradet G, Helms P, Higenbottam T, de Leval M, Wallwork J. Heart-lung transplantation in children. Transplant Proc. 1990 Aug; 22(4):1470-1.
    View PubMed
  85. Whitehead B, James I, Helms P, Scott JP, Smyth R, Higenbottam TW, McGoldrick J, English TAH, Wallwork J, Elliott M, de Leval M. Intensive care management of children following heart and heart-lung transplantation. Intensive Care Medicine. 1990; 16(7):426-30.
    View PubMed
  86. Otulana BA, Higenbottam T, Scott J, Clelland C, Igboaka G, Wallwork J. Lung function associated with histologically diagnosed acute lung rejection and infection in heart-lung transplant patients. Am Rev Respir Dis. 1990 Aug; 142(2):329-32.
  87. Smyth RL, Scott JP, Higenbottam TW, Whitehead B, Helms P, Sharples L, Fradet G, de Leval M, Wallwork J. The use of heart-lung transplantation in management of terminal respiratory complications of cystic fibrosis. Transplant Proc. 1990 Aug; 22(4);1472-73.
  88. Tan KK, Hue KL, Strickland SE, Trull AK, Smyth RL, Scott JP, Kelman AW, Whiting B, Higenbottam TW, Wallwork J. Altered pharmacokinetics of cyclosporin in heart-lung transplant recipients with cystic fibrosis. Ther Drug Monit. 1990 Nov; 12(6):520-4.
  89. McGoldrick JP, Scott JP, Smyth R, Higenbottam TW, Wallwork J. Early graft function after heart-lung transplantation. J Heart Transplant. 1990 Nov; 9(6):693-8.
    View PubMed
  90. Wreghitt TG, Smyth RL, Scott JP, Higenbottam T, Gray JJ, Stewart S, Wallwork J. Value of culture of biopsy material in diagnosis of viral infection in heart-lung transplant recipients. Transplant Proc. 1990 Aug; 22(4):1809-10.
    View PubMed
  91. Trull AK, Hue K, Tan K, Gore S, Whitewood S, Smyth R, Scott J, Price C, Wallwork J. Cross-correlation of cyclosporine concentrations and biochemical measures of kidney and liver function in heart and heart-lung transplant recipients. Clin Chem. 1990 Aug; 36(8 Pt 1):1474-8.
    View PubMed
  92. Smyth RL, Scott JP, Higenbottam TW, Wreghitt TG, Stewart S, Clelland CA, Wallwork J. Experience of cytomegalovirus infection in heart-lung transplant recipients. Transplant Proc. 1990 Aug; 22(4):1820-1.
    View PubMed
  93. Mullins P, Scott JP, Wallwork J. Heart and Heart-lung transplantation Current Opinion in Immunology. 1990; 2:837-41.
  94. Smyth RL, Scott JP, Mullins P, Schofield P, Large SR, Wallwork J. Pediatric Heart Transplantation. Ann Thorac Surg. 1990 Aug; 50(2):333.
  95. Smyth RL, Scott JP, McGoldrick J, Wallwork J, Higenbottam T. Successful use of repeated transbronchial lung biopsies in a patient with multiple opportunistic infections. Respir Med. 1989; 83(6):505-7.
  96. Hutter JA, Scott JP, Deespins P, Stewart S, Higenbottam T, Wallwork J. Heart-lung transplantation at Papworth Hospital. Eur J Cardiothorac Surg. 1989; 3(4):300-3; discussion 303-4.
  97. Otulana BA, Mist BA, Scott JP, Wallwork J, Higenbottam T. The effect of recipient lung size on lung physiology after heart-lung transplantation. Transplantation. 1989; 48(4):625-9.
  98. Smyth RL, Higenbottam TW, Scott JP, Wallwork J. Transplantation of the lungs. Respir Med. 1989; 83(6):459-66.
  99. Smyth RL, Higenbottam TW, Scott JP, McGoldrick JP, Whitehead B, Helms P, de Leval M, Wallwork J. Early experience of heart-lung transplantation. Arch Dis Child. 1989 Sep; 64(9):1225-9; discussion 1229-30.
  100. Hutter JA, Stewart S, Higenbottam T, Scott JP, Wallwork J. The characteristic histological changes associated with rejection in heart-lung transplant recipients. Transpl Proc. 1989 Feb; 21(1 pt 1):435-6.
  101. Hutter JA, Scott J, Wreggit T, Higenbottam T, Wallwork J. The importance of cytomegalovirus in heart-lung transplant recipients. Chest. 1989; 95(3):627-31.
  102. Wreghitt TG, Sargaison M, Sutehall G, Woodward CG, Scott J, English TA, Wallwork J. A study of Ebstein-Barr virus infections in heart and heart and lung transplant recipients. Transpl Proc. 1989 Feb; 21(1 Pt 3):2502-3.
  103. Otulana BA, Higenbottam TW, Scott JP, Clelland C, Hutter JA, Wallwork J. Pulmonary function monitoring allows diagnosis of rejection in heart-lung recipients. Transpl Proc. 1989 Feb; 21(1 Pt 1):2583-4.
  104. Smyth RL, Scott JP, McGoldrick JP, Higenbottam TW, Wallwork J. Heart-lung transplantation for cystic fibrosis. IACFA. 1989; 18:4-7.
  105. Smyth RL, Scott JP, McGoldrick JP, Higenbottam TW, Wallwork J. Update on success with heart-lung transplantation for cystic fibrosis. Brit J Hosp Med ( 1989 May; suppl).
  106. Scott JP, Higenbottam TW, Clelland C, Hutter JA, Steward S, Otulana BA, Wallwork J. The natural history of obliterative bronchiolitis and occlusive vascular disease of patients following heart-lung transplantation. Transpl Proc. 1989 Feb; 21(1 Pt 3):2592-3.
  107. Wood A, Higenbottam T, Jackson M, Scott J, Stewart S, Wallwork J. Airway mucosal bioelectric potential difference in cystic fibrosis after lung transplantation. Am Rev Respir Dis. 1989 Dec; 140(6):1645-9.
    View PubMed
  108. McGoldrick JP, Scott J, Jamieson A, Smyth R, Higenbottam T, Wallwork J. Early graft function following heart and lung transplantation. Transpl Int. 1989 Aug; 2(2):68-72.
  109. Fabbri A, Scott JP, McGoldrick J, Smyth RL, Fradet G, Higenbottam TW, deLeval M, Wallwork J. [Clinical applications of the heart-lung transplant. Clinical results 5 years after the start of the program at Papworth]Italian. G Ital Cardiol. 1989 Nov; 19(11):989-98.
  110. Wreghitt TG, Hakim M, Gray JJ, Balfour AH, Stovin PG, Stewart S, Scott J, English TA, Wallwork J. Toxoplasmosis in heart and lung transplant recipients. J Clin Pathol. 1989 Feb; 42(2):194-9.
  111. Otulana BA, Higenbottam TW, Scott JP, Wallwork J. Exercise hyperventilation following heart-lung transplantation (HLTx): A role for mixed venous oxygen tension. Am Rev Resp Dis. 1989; 139.
  112. Scott JP, Higenbottam T, Hutter J, Hodson M, Stewart S, Penketh A, Wallwork J. Heart-lung transplantation for cystic fibrosis. Lancet. 1988 Jul 23;2(8604):192-4.
  113. Scott JP, Higenbottam TW. Pulmonary hypertension. Hospital Update , 1988; 14:1361-70.
  114. Scott JP, Higenbottam TW. Adverse reactions and interactions of cyclosporin. Medical Toxicol Adverse Drug Exp. 1988 Mar-Apr; 3(2):107-27.
  115. Scott JP, Hutter JA, Higenbottam TW, Wallwork J. Combined heart-lung transplantation Practice in Cardiology. 1988; 6:21-41.
  116. Moore NR, Scott JP, Flower CD, Higenbottam TW. The relationship between pulmonary artery pressure and main pulmonary artery diameter in pulmonary hypertension. Clin Radiol. 1988 Sep; 39(5):486-9.
  117. Hutter JA, Stewart S, Higenbottam T, Scott JP, Wallwork J. Histological changes in heart-lung transplant recipients during rejection episodes and at routine biopsy. J Heart Transplant. 1988 Nov-Dec; 7(6):440-4.
  118. Jones DK, Luddington R, Higenbottam TW, Scott J, Cavarocchi N, Reardon D, Calvin J, Wallwork J. Changes in factor VIII proteins after cardiopulmonary bypass in man suggests endothelial damage. Thrombosis Haemost. 1988 Oct 31; 60(2):199-204.
  119. Scott JP, Hutter JA, Higenbottam TW, Hodson ME, Wallwork J. Heart-lung transplantation for Cystic Fibrosis. Thorax. 1988;43:838.
  120. Scott JP, Nunez D, Reardon D, Luddington R, Folawski J, Evans DB, Higenbottam TW, Calne R. Effect of cyclosporine on platelet aggregation in renal transplant recipients. Transplant Proc. 1987; 19(5):4008.
  121. Scott JP, Nunez D, Hay IF, Higenbottam TW, Evans DB, Calne R. Exercise-induced hypertension in normotensive renal transplant recipients receiving cyclosporine A. Transplant Proc. 1987; 19(5):4002.
  122. Scott JP, Jolly KD, McKinnon MJ, Clarke AM. Melanoma in Otago and Southland. N Z Med J , 1984; 92:422-4.
  123. Jolly KD, Scott JP, McKinnon MJ, Clarke AM. Diagnosis and survival in carcinoma of the large bowel. Aust N Z J Surg. 1982; 52:12-6.